I am a pathologist who is trained in gastrointestinal surgical pathology and as a basic scientist with a focus on molecular pathophysiology of the gastrointestinal tract. My primary specialty is digestive diseases, particularly cancers of the gastrointestinal tract and the pancreas. I also specialize in gastroesophageal reflux disease (GERD) and Barrett’s esophagus, and have a special interest in gastrointestinal neuroendocrine tumors and carcinoid disease.
My investigative research involves elucidating the molecular mechanisms of cell proliferation and the regulation of malignant cell transformation, both with the goal of developing molecular techniques that will improve the early diagnosis and treatment of gastrointestinal tract cancers. I am currently involved in a multidisciplinary investigation of Barrett’s-related dysplasia and esophageal cancer. My career goals are to maintain excellence in the area of surgical pathology and diagnosis, and to improve patient care by developing strategies to speed the evolution of the field of morphologic pathology into a new era of functional and molecular pathology.
- Clinical Expertise: Surgical Pathology; Pathology of Digestive Diseases
- Languages Spoken: English
- Education: MD, Capital University of Medicine and Sciences (Beijing, China); PhD, Emory University School of Medicine
- Residencies: Yale-New Haven Hospital
- Fellowships: Memorial Sloan Kettering Cancer Center
- Board Certifications: Anatomical Pathology
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more